5 results  1 of 1 

1 Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis
Yun-Jin Hwang, Jung-Hyun Park, Du-Hyong Cho
J Korean Med Sci.2020;35(35):e289.  Published online 2020 August 5     DOI: http://dx.doi.org/10.3346/jkms.2020.35.e289
      
2 mTOR-coordinated Post-Transcriptional Gene Regulations: from Fundamental to Pathogenic Insights
Hsin-Sung Yeh, Jeongsik Yong
J Lipid Atheroscler.2020;9(1):8-22.   Published online 2019 October 18     DOI: http://dx.doi.org/10.12997/jla.2020.9.1.8
      
3 Acute Hyperglycemia Associated with Anti-Cancer Medication
Yul Hwangbo, Eun Kyung Lee
Endocrinol Metab.2017;32(1):23-29.   Published online 2017 March 20     DOI: http://dx.doi.org/10.3803/EnM.2017.32.1.23
   
4 Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
Katherine M. Krajewski, Marta Braschi-Amirfarzan, Pamela J. DiPiro, Jyothi P. Jagannathan, Atul B. Shinagare
Korean J Radiol.2017;18(1):28-41.   Published online 2017 January 5     DOI: http://dx.doi.org/10.3348/kjr.2017.18.1.28
      
5 The Inhibition of Insulin-stimulated Proliferation of Vascular Smooth Muscle Cells by Rosiglitazone Is Mediated by the Akt-mTOR-P70S6K Pathway
Sungha Park, Soyeon Lim, Woochul Chang, Heesang Song, Sunju Lee, Byeong-Wook Song, Hye-Jung Kim, Min-Ji Cha, Eunju Choi, Yangsoo Jang, Namsik Chung, Seung Yun Cho, Ki-Chul Hwang
Yonsei Med J.2008;49(4):592-600.   Published online 2008 August 30     DOI: http://dx.doi.org/10.3349/ymj.2008.49.4.592
      

 1 of 1